A citation-based method for searching scientific literature

N Shukla, M F Levine, G Gundem, D Domenico, B Spitzer, N Bouvier, J E Arango-Ossa, D Glodzik, J S Medina-Martínez, U Bhanot, J Gutiérrez-Abril, Y Zhou, E Fiala, E Stockfisch, S Li, M I Rodriguez-Sanchez, T O'Donohue, C Cobbs, M H A Roehrl, J Benhamida, F Iglesias Cardenas, M Ortiz, M Kinnaman, S Roberts, M Ladanyi, S Modak, S Farouk-Sait, E Slotkin, M A Karajannis, F Dela Cruz, J Glade Bender, A Zehir, A Viale, M F Walsh, A L Kung, E Papaemmanuil. Nat Commun 2022
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.
Stefan M Pfister, Miguel Reyes-Múgica, John K C Chan, Henrik Hasle, Alexander J Lazar, Sabrina Rossi, Andrea Ferrari, Jason A Jarzembowski, Kathy Pritchard-Jones, D Ashley Hill,[...]. Cancer Discov 2022
14
66

Pan-cancer whole-genome analyses of metastatic solid tumours.
Peter Priestley, Jonathan Baber, Martijn P Lolkema, Neeltje Steeghs, Ewart de Bruijn, Charles Shale, Korneel Duyvesteyn, Susan Haidari, Arne van Hoeck, Wendy Onstenk,[...]. Nature 2019
354
33


Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
289
33

Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.
Joris van de Haar, Louisa R Hoes, Paul Roepman, Martijn P Lolkema, Henk M W Verheul, Hans Gelderblom, Adrianus J de Langen, Egbert F Smit, Edwin Cuppen, Lodewyk F A Wessels,[...]. Nat Med 2021
17
33

Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems.
Nicola Normanno, Kathi Apostolidis, Francesco de Lorenzo, Philip A Beer, Raymond Henderson, Richard Sullivan, Andrew V Biankin, Denis Horgan, Mark Lawler. Semin Cancer Biol 2022
7
33

Whole-genome and transcriptome analysis enhances precision cancer treatment options.
E Pleasance, A Bohm, L M Williamson, J M T Nelson, Y Shen, M Bonakdar, E Titmuss, V Csizmok, K Wee, S Hosseinzadeh,[...]. Ann Oncol 2022
3
33

An analysis of genetic heterogeneity in untreated cancers.
Johannes G Reiter, Marina Baretti, Jeffrey M Gerold, Alvin P Makohon-Moore, Adil Daud, Christine A Iacobuzio-Donahue, Nilofer S Azad, Kenneth W Kinzler, Martin A Nowak, Bert Vogelstein. Nat Rev Cancer 2019
87
33

Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
Philip A Beer, Susanna L Cooke, David K Chang, Andrew V Biankin. Ann Oncol 2019
4
33


Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.
Marie Wong, Chelsea Mayoh, Loretta M S Lau, Dong-Anh Khuong-Quang, Mark Pinese, Amit Kumar, Paulette Barahona, Emilie E Wilkie, Patricia Sullivan, Rachel Bowen-James,[...]. Nat Med 2020
85
33

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.
Pablo Berlanga, Gaelle Pierron, Ludovic Lacroix, Mathieu Chicard, Tiphaine Adam de Beaumais, Antonin Marchais, Anne C Harttrampf, Yasmine Iddir, Alicia Larive, Aroa Soriano Fernandez,[...]. Cancer Discov 2022
8
33

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Xiaotu Ma, Yu Liu, Yanling Liu, Ludmil B Alexandrov, Michael N Edmonson, Charles Gawad, Xin Zhou, Yongjin Li, Michael C Rusch, John Easton,[...]. Nature 2018
395
33

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Keith T Flaherty, Robert J Gray, Alice P Chen, Shuli Li, Lisa M McShane, David Patton, Stanley R Hamilton, P Mickey Williams, A John Iafrate, Jeffrey Sklar,[...]. J Clin Oncol 2020
78
33

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.
Cornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, Karin P S Langenberg, Petra Fiesel, Barbara C Jones, Gnana Prakash Balasubramanian, Sebastian Stark, Pascal D Johann, Mirjam Blattner-Johnson,[...]. Cancer Discov 2021
26
33

DNA methylation-based classification of central nervous system tumours.
David Capper, David T W Jones, Martin Sill, Volker Hovestadt, Daniel Schrimpf, Dominik Sturm, Christian Koelsche, Felix Sahm, Lukas Chavez, David E Reuss,[...]. Nature 2018
33

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Alanna J Church, Laura B Corson, Pei-Chi Kao, Alma Imamovic-Tuco, Deirdre Reidy, Duong Doan, Wenjun Kang, Navin Pinto, Luke Maese, Theodore W Laetsch,[...]. Nat Med 2022
2
50

The landscape of genomic alterations across childhood cancers.
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, Ivo Buchhalter, Kortine Kleinheinz, Vasilisa A Rudneva, Pascal D Johann, Gnana Prakash Balasubramanian, Maia Segura-Wang, Sebastian Brabetz,[...]. Nature 2018
639
33

The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
Bing Dai, Hao Yu, Tingting Ma, Yichen Lei, Jiyue Wang, Yunxiang Zhang, Jing Lu, Han Yan, Lu Jiang, Bing Chen. J Mol Diagn 2021
1
100

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML).
Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, Rakhi Salve, Prasanna Bhanshe, Gaurav Chatterjee, Sweta Rajpal, Swapnali Joshi, Shruti Chaudhary, Rohan Kodgule,[...]. Leukemia 2021
18
33

Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
María Chicano, Diego Carbonell, Julia Suárez-González, Sergio Lois, Mercedes Ballesteros-Culebras, Cristina Andrés-Zayas, Paula Muñiz, Gabriela Rodríguez-Macias, Mariana Bastos-Oreiro, Patricia Font,[...]. Cancers (Basel) 2021
1
100

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
Eric J Duncavage, Molly C Schroeder, Michele O'Laughlin, Roxanne Wilson, Sandra MacMillan, Andrew Bohannon, Scott Kruchowski, John Garza, Feiyu Du, Andrew E O Hughes,[...]. N Engl J Med 2021
62
33

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
33

Unified classification and risk-stratification in Acute Myeloid Leukemia.
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie Freeman, Yoann Pradat, Sean J Johnson, Robert Hills,[...]. Nat Commun 2022
4
33

Molecular Genetics of Pediatric Acute Myeloid Leukemia.
Bryan Krock, Matthew J Oberley. Clin Lab Med 2021
2
50


Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.
Elisabeth K M Mack, André Marquardt, Danny Langer, Petra Ross, Alfred Ultsch, Michael G Kiehl, Hildegard I D Mack, Torsten Haferlach, Andreas Neubauer, Cornelia Brendel. Haematologica 2019
26
33

Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring.
Erin L Crowgey, Nitin Mahajan, Wing Hing Wong, Anilkumar Gopalakrishnapillai, Sonali P Barwe, E Anders Kolb, Todd E Druley. BMC Med Genomics 2020
8
33

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Christoph Röllig, Michael Kramer, Christoph Schliemann, Jan-Henrik Mikesch, Björn Steffen, Alwin Krämer, Richard Noppeney, Kerstin Schäfer-Eckart, Stefan W Krause, Mathias Hänel,[...]. Blood 2020
45
33

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.
Carmen M Alonso, Marta Llop, Claudia Sargas, Laia Pedrola, Joaquín Panadero, David Hervás, José Cervera, Esperanza Such, Mariam Ibáñez, Rosa Ayala,[...]. J Mol Diagn 2019
16
33

Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms.
Joonhong Park, Hoon Seok Kim, Jong-Mi Lee, Jin Jung, Dain Kang, Hayoung Choi, Gun Dong Lee, Jungok Son, Silvia Park, Byung-Sik Cho,[...]. Mol Diagn Ther 2020
6
33

A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia.
T Roderick Docking, Jeremy D K Parker, Martin Jädersten, Gerben Duns, Linda Chang, Jihong Jiang, Jessica A Pilsworth, Lucas A Swanson, Simon K Chan, Readman Chiu,[...]. Nat Commun 2021
20
33

Cancer transcriptome profiling at the juncture of clinical translation.
Marcin Cieślik, Arul M Chinnaiyan. Nat Rev Genet 2018
117
33

Precision oncology for acute myeloid leukemia using a knowledge bank approach.
Moritz Gerstung, Elli Papaemmanuil, Inigo Martincorena, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Michael Heuser, Felicitas Thol, Niccolo Bolli, Peter Ganly,[...]. Nat Genet 2017
155
33

Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.
Hassan Awada, Arda Durmaz, Carmelo Gurnari, Ashwin Kishtagari, Manja Meggendorfer, Cassandra M Kerr, Teodora Kuzmanovic, Jibran Durrani, Jacob Shreve, Yasunobu Nagata,[...]. Blood 2021
7
33


Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
Almudena Aguilera-Diaz, Iria Vazquez, Beñat Ariceta, Amagoia Mañú, Zuriñe Blasco-Iturri, Sara Palomino-Echeverría, María José Larrayoz, Ramón García-Sanz, María Isabel Prieto-Conde, María Del Carmen Chillón,[...]. PLoS One 2020
21
33

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Hartmut Döhner, Andrew H Wei, Frederick R Appelbaum, Charles Craddock, Courtney D DiNardo, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian,[...]. Blood 2022
21
33

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.
Svea Stratmann, Sara A Yones, Markus Mayrhofer, Nina Norgren, Aron Skaftason, Jitong Sun, Karolina Smolinska, Jan Komorowski, Morten Krogh Herlin, Christer Sundström,[...]. Blood Adv 2021
13
33

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Claudia Sargas, Rosa Ayala, María Carmen Chillón, María J Larráyoz, Estrella Carrillo-Cruz, Cristina Bilbao, Manuel Yébenes-Ramírez, Marta Llop, Inmaculada Rapado, Ramón García-Sanz,[...]. Haematologica 2021
5
33

Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies.
Sorina Mihaela Papuc, Alina Erbescu, Diana Cisleanu, Diana Ozunu, Cristina Enache, Ion Dumitru, Elena Lupoaia Andrus, Mihaela Gaman, Viola Maria Popov, Maria Dobre,[...]. Genes (Basel) 2021
2
50

Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse.
Esther Onecha, Inmaculada Rapado, María Luz Morales, Gonzalo Carreño-Tarragona, Pilar Martinez-Sanchez, Xabier Gutierrez, José María Sáchez Pina, María Linares, Miguel Gallardo, Joaquín Martinez-López,[...]. Haematologica 2021
13
33

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans-Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford,[...]. Blood 2022
35
33

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Lok Lam Ngai, Jesse M Tettero, Costa Bachas, Constance Baer, Marie-Christine Béné,[...]. Blood 2021
63
33

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators.
Maarten Fornerod, Jing Ma, Sanne Noort, Yu Liu, Michael P Walsh, Lei Shi, Stephanie Nance, Yanling Liu, Yuanyuan Wang, Guangchun Song,[...]. Blood Cancer Discov 2021
5
33

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Joseph D Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Jane F Apperley, Rafael Bejar, Emilio Berti, Lambert Busque, John K C Chan,[...]. Leukemia 2022
74
33

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
33

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission.
Madlen Jentzsch, Lara Bischof, Donata Backhaus, Dominic Brauer, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind. Blood Adv 2022
2
50

Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli,[...]. N Engl J Med 2016
33

Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.
Franck Rapaport, Yaseswini Neelamraju, Timour Baslan, Duane Hassane, Agata Gruszczynska, Marc Robert de Massy, Noushin Farnoud, Samuel Haddox, Tak Lee, Juan Medina-Martinez,[...]. Leukemia 2021
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.